Authors:
FISHERMAN JS
COWAN KH
NOONE M
DENICOFF A
BERG S
POPLACK D
BALIS F
VENZON D
MCCABE M
GOLDSPIEL B
CHOW C
OGNIBENE FP
OSHAUGHNESSY J
Citation: Js. Fisherman et al., PHASE I II STUDY OF 72-HOUR INFUSIONAL PACLITAXEL AND DOXORUBICIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC BREAST-CANCER/, Journal of clinical oncology, 14(3), 1996, pp. 774-782
Authors:
BERG SL
COWAN KH
BALIS FM
FISHERMAN JS
DENICOFF AM
HILLIG M
POPLACK DG
OSHAUGHNESSY JA
Citation: Sl. Berg et al., PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION, Journal of the National Cancer Institute, 86(2), 1994, pp. 143-145
Citation: Ja. Oshaughnessy et al., COMBINATION PACLITAXEL (TAXOL) AND DOXORUBICIN THERAPY FOR METASTATICBREAST-CANCER, Seminars in oncology, 21(5), 1994, pp. 19-23
Authors:
TRIMBLE EL
ADAMS JD
VENA D
HAWKINS MJ
FRIEDMAN MA
FISHERMAN JS
CHRISTIAN MC
CANETTA R
ONETTO N
HAYN R
ARBUCK SG
Citation: El. Trimble et al., PACLITAXEL FOR PLATINUM-REFRACTORY OVARIAN-CANCER - RESULTS FROM THE FIRST 1,000 PATIENTS REGISTERED TO NATIONAL-CANCER-INSTITUTE TREATMENT-REFERRAL-CENTER-9103, Journal of clinical oncology, 11(12), 1993, pp. 2405-2410